← Open Payments lookup

MAHINDRANAUTH DEONARINE: Open Payments

NPI 1841253127 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$457 in 23 payments from 3 companies in 2025. Trend: 2023 $279 · 2024 $306 · 2025 $457

Food & beverage: $457
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$230
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$190
Alkermes, Inc.2$37

Products named: REXULTI, CAPLYTA, ARISTADA.

Industry payments across MD — which companies pay providers there.